Clinical trial · Interventional
Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas
Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas.
NCT01619696CI-TRIAL-00009056terminatedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient recruitment
Summary
Brief summary (as posted)
The objective of the present project is to validate the feasibility of a multimodal radiological pathway while on chemoradiotherapy, in order to validate potentially predictive factors for chemoradiotherapy sensitivity of rectal adenocarcinomas.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Adenocarcinoma | Rectal Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pelvic MRI and F MISO TEP | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention
- interventionNames
- Procedure: Pelvic MRI and F MISO TEP
Primary outcomes (1)
- measure
- acceptation rate of the entire sequence by eligible patients
- timeFrame
- 13 weeks
- description
- acceptation rate of the entire sequence by eligible patients
Secondary outcomes (1)
- measure
- radiological changes while on chimiotherapy, to tumour regression, and prognosis
- timeFrame
- 13 weeks
- description
- radiological changes while on chimiotherapy, to tumour regression, and prognosis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * locally advanced (≥T3) resectable rectal adenocarcinoma between 2 and 10 cm from the anal verge. Exclusion Criteria: * synchonous metastatis * previous malignant tumour * previous radiotherapy/ chemotherapy * performance status WHO\>2 * contraindication to 5 FU
References
Publications (0)
Data not yet available
No reference posted for this study.